Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients
NCT02612948Phase 4Completed
- Sponsor
- University of Tennessee Graduate School of Medicine
- Start
- Nov 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine in delirium, sponsored by University of Tennessee Graduate School of Medicine. Started Nov 2013; status: completed.
02
Drugs
quetiapine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT02612948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02612948.